Authors
Pham T.Z.1, 2, Frolov M.A.1, 2, Shklyaruk V.V.1, 2, Melnichenko S.V.1, 2
1 Peoples’ Friendship University of Russia named after Patrice Lumumba, Moscow
2 Eye Prosthetics Center, Moscow
Abstract
New drugs and methods of early diagnosis of malignant tumors of the visual organ have appeared in the last decades. Nevertheless, the problem of untimely diagnosis and treatment of these diseases remains in practical ophthalmology, which leads to more radical and less organ-preserving methods of treatment and, as a consequence, to the deterioration of cosmetic and functional results in subsequent eye prosthetics.
Aim. To analyze and discuss the literature on the following topics: ocular prosthetics and ophthalmic oncology using available databases.
Material and methods. Optimization of domestic and foreign scientific papers using eLibrary, PubMed, ScienceDirect and Google Scholar databases.
Results. The 52 most relevant sources of domestic and foreign literature were analyzed.
Conclusions. Having analyzed the literature data in domestic and foreign sources, we can conclude that the world medical community has not fully disclosed the issue of eye prosthetics in patients after oncological treatment. More research and practical recommendations are needed in this area. The use of a staggered prosthetic method, as well as the shape of the eye prosthesis, taking into account the individual characteristics of the conjunctival cavity, will help to achieve the best results.
Keywords: eye prosthetics, ophthalmo-oncology, radiation therapy, customized prosthetics, retinoblastoma, uveal melanoma.
References
1. Gundorova R.A., Druyanova Yu.S. Korrektsiya kon”yunktival’noi polosti dlya kosmeticheskogo protezirovaniya // Vestnik oftal’mologii. – 1988 – № 5 – S. 57-58. (In Russ.)
2. Yarovoi A.A., Kotel’nikova A.V., Kotova E.S., Volodin D.P., Ushakova T.L. Primary endoprosthetics of the orbit during enucleation for retinoblastoma// Rossiiskaya detskaya oftal’mologiya № 1 – 2021.
3. Brovkina AF, Panova IE, Saakian SV. Ophthalmic oncology: achievements over the last two decades. Russian Annals of Ophthalmology. 2014;130(6):13 19. (In Russ.)
4. Kosharnaya N.V. Glaznoe protezirovanie: Prakticheskoe posobie dlya okulistov i glazoprotezistov. – Khar’kov, 1996 – 83 s. (In Russ.)
5. Krasil’nikova V. L. Integriruemyi podvizhnyi orbital’nyi implantat iz kompozitsionnoi vysokoporistoi keramiki / V. L. Krasil’nikova, O. L. Smorygo // Oftal’mologiya. Vostochnaya Evropa. – 2011. – № 3 (10). – S. 17–28. (In Russ.)
6. Perfil’eva E. A. Effektivnost’ glaznogo protezirovaniya: posternyi doklad / E. A. Perfil’eva, M. A. Frolov, V. V. Shklyaruk // «Aktual’nye voprosy oftal’mologii – 2014». – M.: MNTK Mikrokhirurgiya glaza im. S.N. Fedorova, 2014. (In Russ.)
7. Filatova, I. A. Anoftal’m. Patologiya i lechenie / I. A. Filatova. – M., 2007. – 215 s. (In Russ.)
8. Brzheskii, V. V. Sindrom «sukhogo glaza» / V. V. Brzheskii // Oftal’molo-giya. Natsional’noe rukovodstvo. Kratkoe izdanie / pod red. S. E. Avetisova, E. A. Egorova, L. K. Moshetovoi, V. V. Neroeva, Kh. P. Takhchidi. – M.: GEOTAR-Media, 2008. – S. 388–399. (In Russ.)
9. Perfil’eva, E. A. Issledovanie kachestva zhizni u patsientov s glaznymi protezami / E. A. Perfil’eva, M. A. Frolov, V. V. Shklyaruk // Kachestvo zhizni, psikhologiya zdorov’ya i obrazovanie: mezhdistsiplinarnyi podkhod. Materialy Mezhdunarodnoi nauchno-prakticheskoi konferentsii. – 2014. – S. 227–229. (In Russ.)
10. Kashnikova, O. A. Profilaktika i terapiya simptomaticheskogo sukhogo glaza v fotorefraktsionnoi khirurgii / O. A. Kashnikova, D. Yu. Maichuk, V. V. Kurenkov // Refraktsionnaya khirurgiya i oftal’mologiya. – 2001. – T. 1, № 3. – C. 22–26. (In Russ.)
11. Shklyaruk V.V. Problemy i puti povysheniya effektivnosti glaznogo protezirovaniya. Avtoreferat dissertatsii na soiskanie uchenoi stepeni kandidata nauk. Oftal’mologiya. M. 2005 g. 24 s. (In Russ.)
12. Luzyanina V.V. Ophthalmoplasty in ocular prosthetics. Pacific Medical Journal. 2016;61(3):32-35. (In Russ.)
13. Al’ Khatib Nashaat Sultan Afif. Osobennosti glaznogo protezirovaniya u patsientov s sakharnym diabetom. Avtoreferat dissertatsii na soiskanie uchenoi stepeni kandidata nauk. Oftal’mologiya. M. 2021 g. 25 s. (In Russ.)
14. Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology.1997;104(8):1265-1276. https://doi.org/10.1016/S0161-6420(97)30148-1
15. Ferry AP, Font RL. Carcinoma metastatic to the eye and orbit: I. A Clinicopathologic study of 227 cases. Arch Ophthalmol. 1974;92(4):276-286.
16. Nylen U, Kock E, Lax I, Lundell G, Af Trampe E, Wilking N. Standardized precision radiotherapy in choroidal metastases. Acta Ophthalmol. 1994;33(1):65-68
17. Peyman GA, Sanders DR, Goldberg MF. Anatomy of the orbit. In: Kozoil J ed. Principles and Practice of Ophthalmology. Eye and Ear Infirmary, Vol. 1. Chicago: University of Illinois at the Medical Center, 1987: 69.
18. Taicher S, Steinberg HM, Tubiana I, Sela M. Modified stock-eye ocular prosthesis. J Prosthet Dent 1985; 54: 95–98.
19. Peyman GA, Sanders DR, Goldberg MF. Enucleation and evisceration. In: Witteman GJ, Scott R eds. Principles and Practice of Ophthalmology, Vol. 3. New Delhi, India: Jaypee Publishers, 1987: 2334.
20. Ow RKK, Amrith S. Ocular prosthetics: use of a tissue conditioner material to modify a stock ocular prosthesis. J Prosthet Dent 1997; 78: 218–222.
21. Bartlett SO, Moore DJ. Ocular prosthesis: a physiologic system. J Prosthet Dent 1973; 29: 450–459.
22. Shildkrot Y., Kirzhner M., Haik B.G. et al. The effect of cancer therapies on pediatric anophthalmic sockets. Ophthalmology. 2011; 118 (12): 2480–2486.
23. Lang P., Kim J.W., McGovern K. et al. Porous orbital implant after enucleation in retinoblastoma patients: indications and complications. Orbit. 2018; 37 (6): 438–443.
24. Mourits D.L., Hartong D.T., Bosscha M.I. et al. Worldwide enucleation techniques and materials for treatment of retinoblastoma: an international survey. PLoS One. 2015; 10 (3): e0121292.
25. Mules P.H. Evisceration of the giobe with artificial vitreous. Ophthalmol Soc UK. 1885; 5: 200–208.
26. Neuhaus R.W., Greider B., Baylis H.I. Enucleation with implantation of a proplast sphere. Ophthalmology. 1984; 91 (5): 494–496.
27. Nunery W.R., Cepela, M.A., Heinz G.W. et al. Extrusion rate of silicone spherical anophthalmic socket implants. Ophthalmic plastic and reconstructive surgery. 1993; 9 (2): 90–95.
28. Cohen V.M., Carter M.J., Kemeny A. Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation. Acta Ophthalmol. Scand. 2003; 81 (4): 383—388.
29. Zorlu F., Selek U., Kiratli H. Initial results of fractionated Cyberknife radiosurgery for uveal melanoma. J. Neurooncol. 2009; 94 (1): 111—117.
30. Zehetmayer M. Stereotactic photon beam irradiation of uveal melanoma. Dev. Ophthalmol. 2012; 49: 58—65.
31. Krema H., Somani S., Sahgal A. Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow up. Br. J. Ophthalmol. 2009; 93 (9): 1172—1176.
32. Singh A.D., Topham A. Survival rates with uveal melanoma in the United States: 1973—1997. Ophthalmology. 2003; 110 (5): 962—965.
33. Damato B. Detection of uveal melanoma by optometrists in the United Kingdom. Ophthalmic. Physiol. Opt. 2001; 21 (4): 268—271.
34. Eskelin S., Kivelä T. Mode of presentation and time to treatment of uveal melanoma in Finland. Br. J. Ophthalmol. 2002; 86 (3): 333—338.
35. Edge S., Byrd D.R., Compton C.C., Fritz A.G., Greeene F.L, Trotti A., eds. Uveal melanoma. AJCC
36. Kim SE, Yoon JS, Lee SY. Tear measurement in prosthetic eye users with fourier-domain optical coherence tomography. Am J Ophthalmol 2010; 149:602–607.
37. Poh S, Lee R, Gao J, et al. Factors that influence tear meniscus area and conjunctivochalasis: The Singapore Indian eye study. Ophthalmic Epidemiol 2018;25:70–78.
38. Ong BL, Larke JR. Meibomian gland dysfunction: Some clinical, biochemical and physical observations. Ophthalmic Physiol Opt 1990;10:144–148.
39. Jester JV, Nicolaides N, Kiss-Palvolgyi I, et al. Meibomian gland dysfunction II: The role of keratinization in a rabbit model of MGD. Invest Ophthalmol Vis Sci 1989;30:936–945.
40. Jester JV, Rajagopalan S, Rodrigues M. Meibomian gland changes in the rhino mouse. Invest Ophthalmol Vis Sci 1988;29:1190–1194.
41. Redlich FC, Callahan A, Schmedtje JF. Electrical potentials from eye movements.Yale J Biol Med 1946;18:269–274.
42. Henriquez AS, Korb DR. Meibomian glands and contact lens wear. Br J Ophthalmol 1981;65:108–111.
43. Herbaut A, Liang H, Denoyer A, et al. Tear film analysis and evaluation of optical quality: A review of the literature. J Fr Ophtalmol 2019;42:e21–e35.
44. Del Aguila-Carrasco AJ, Ferrer-Blasco T, Garcia-Lazaro S, et al. Assessment of corneal thickness and tear meniscus during contact-lens wear. Cont Lens Anterior Eye 2015;38:185–193.
45. Huang Y, Sheha H, Tseng SC. Conjunctivochalasis interferes with tear flow from fornix to tear meniscus. Ophthalmology 2013;120:1681–1687.
46. Bandlitz S, Purslow C, Murphy PC, et al. Influence of conjunctival folds on calculated tear meniscus volume along the lower eyelid. Ocul Surf 2016;14:377–384.
47. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The international workshop on meibomian gland dysfunction: Report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 2011;52:1930–1937.
48. Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: The role gland dysfunction in dry eye disease. Ophthalmology 2017;124:S20–S26.
49. Arita R, Itoh K, Inoue K, et al. Contact lens wear is associated with decrease of meibomian glands. Ophthalmology 2000;116:379–384.
50. Arita R, Fukuoka S, Morishige N. Meibomian gland dysfunction and contact lens discomfort. Eye Contact Lens 2017;43:17–22.
51. Pult H, Riede-Pult B. Comparison of subjective grading and objective assessment in meibography. Cont Lens Anterior Eye 2013;36:22–27.
52. Arita R, Itoh K, Maeda S, et al. Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology 2009;116:2058–2063.
